Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Smartwatch Heart Monitoring for Atrial Fibrillation Burden

Tests a smartwatch that checks heart rhythm in people with atrial fibrillation.

Plain-language title generated from the registry record
Registry title: Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden

Key facts

Where
Beijing, ChinaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with atrial fibrillation (an irregular heartbeat) confirmed by an electrocardiogram, who are willing to use long-range electrocardiogram monitoring equipment.

Sex
All sexes can join.
Disease stage
Atrial fibrillation diagnosed by electrocardiogram.

Main reasons for not taking part

  • Allergic to electronic devices
  • Unable to wear a watch

Read by machine on 9 November 2026.

Where in China

  • Beijing Anzhen HospitalBeijing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beijing Anzhen Hospital
Trial code
NCT06686940
Record updated
13 November 2024
Original description
The purpose of this study is to evaluate the monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.Read full original descriptionShow less

Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden

The purpose of this study is to evaluate the monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.

Inclusion: Atrial fibrillation patients diagnosed by electrocardiogram; Willing to use long-range electrocardiogram monitoring equipment.

Exclusion: 1.Patients who are allergic to electronic devices or unable to wear watches.

ClinicalTrials.gov NCT06686940